The Clinical Development Team at Elypta designs, manages, and analyzes clinical studies to validate and optimize their metabolism-based liquid biopsy platform for cancer early detection and monitoring. This team ensures robust study protocols, coordinates with clinical sites, and interprets complex data to support regulatory approval and market adoption.
View all